Eikon Therapeutics, Inc.
No trades
No trades
Compare with Eikon Therapeutics, Inc.
−324.25 M USD
0.00 USD
25.25 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Roger M. Perlmutter
Website
Headquarters
Millbrae
Founded
2019
IPO date
Feb 5, 2026
IPO offer price
18.00 USD
ISIN
US2825641036
CUSIP
282564103
FIGI
BBG00T0XRJ75
Identifiers
ISIN US2825641036
Eikon Therapeutics is a biopharmaceutical company. It engages in the development of medicines for unmet medical needs. The company was founded in 2019 and is headquartered in Millbrae, CA.
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Frequently asked questions
The current price of EIKN is 7.58 USD — it has increased by 0.40% in the past 24 hours. Watch Eikon Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eikon Therapeutics, Inc. stocks are traded under the ticker EIKN.
EIKN stock has fallen by −5.16% compared to the previous week, the month change is a −30.25% fall, over the last year Eikon Therapeutics, Inc. has showed a −55.54% decrease.
We've gathered analysts' opinions on Eikon Therapeutics, Inc. future price: according to them, EIKN price has a max estimate of 32.00 USD and a min estimate of 4.00 USD. Watch EIKN chart and read a more detailed Eikon Therapeutics, Inc. stock forecast: see what analysts think of Eikon Therapeutics, Inc. and suggest that you do with its stocks.
EIKN reached its all-time high on Feb 5, 2026 with the price of 17.40 USD, and its all-time low was 7.07 USD and was reached on Oct 2, 2026. View more price dynamics on EIKN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EIKN stock is 7.65% volatile and has beta coefficient of 1.93. Track Eikon Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Eikon Therapeutics, Inc. there?
Today Eikon Therapeutics, Inc. has the market capitalization of 408.40 M, it has decreased by −6.59% over the last week.
Yes, you can track Eikon Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Eikon Therapeutics, Inc. is going to release the next earnings report on Dec 2, 2026. Keep track of upcoming events with our Earnings Calendar.
EIKN earnings for the last quarter are −1.63 USD per share, whereas the estimation was −1.58 USD resulting in a −2.84% surprise. The estimated earnings for the next quarter are −1.70 USD per share. See more details about Eikon Therapeutics, Inc. earnings.
Eikon Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
EIKN net income for the last quarter is −88.41 M USD, while the quarter before that showed −82.96 M USD of net income which accounts for 0.00% change. Track more Eikon Therapeutics, Inc. financial stats to get the full picture.
No, EIKN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EIKN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eikon Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.